Insurance against recurrence Nova seeks to lead a revolution in cancer care by making routine genomics testing a reality for all survivors around the world. We differentiate by providing a non-invasive test with industry-leading performance, but at 10x-less cost than anything offered today. We will sell direct to patients and providers, enabling broad adoption, early detection of tumor recurrence, and thus greater clinical outcomes and quality of life.